Nanobiotix, a late-stage biotech company specializing in nanotherapeutics for cancer and other diseases, has been included in the Euronext Tech Leaders Index. This inclusion highlights the company's innovative approach combining physics and medicine and enhances its visibility to international investors. Being part of this index supports Nanobiotix's growth and mission to develop new therapies that improve patient outcomes worldwide. The company is recognized for its pioneering nanotechnology platforms addressing significant medical needs.
CEA Industries and YZi Labs have reached a cooperation agreement to strengthen governance at CEA Industries, which manages the world's largest corporate treasury of BNB. The agreement includes appointing three new board members with digital asset exp...
uniQure Inc. has priced an upsized public offering of 4,945,055 ordinary shares at $45.50 each, aiming to raise approximately $225 million before expenses. The funds will support the company's development of transformative gene therapies for severe d...
The TBG Dividend Focus ETF maintains a 'hold' rating due to its competitive fundamentals within its category. It offers a robust 12.75% projected EPS growth for next year and an estimated dividend yield of 3.59%, which surpasses its trailing yield of...
Bitcoin has been trading below $70,000 for about three weeks, with recent whale purchases totaling over $43 million failing to push the price above $65,000. Large investors, or whales, have dominated market activity since early June, but their buying...
HYLQ Strategy Corp. sold 54,461 HYPE tokens, generating $3.36 million at an average price of $61.76 each, realizing a 62% gain over its acquisition cost. This sale completes the monetization of its HYPE treasury position, totaling approximately 104,4...
